<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Molecular mechanisms &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/molecular-mechanisms/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 05:53:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Molecular mechanisms &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>LncRNA PVT1 Influences Endothelial Function in DVT</title>
		<link>https://bioengineer.org/lncrna-pvt1-influences-endothelial-function-in-dvt/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 05:52:54 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Deep Vein Thrombosis (DVT)]]></category>
		<category><![CDATA[Endothelial dysfunction]]></category>
		<category><![CDATA[Endothelial Function]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **Deep Vein Thrombosis]]></category>
		<category><![CDATA[lncRNA PVT1]]></category>
		<category><![CDATA[miR-143-3p]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[Molecular Sponge Mechanism]]></category>
		<guid isPermaLink="false">https://bioengineer.org/lncrna-pvt1-influences-endothelial-function-in-dvt/</guid>

					<description><![CDATA[In a groundbreaking study that could reshape our understanding of vascular health, researchers have meticulously dissected the role of long non-coding RNA (lncRNA) PVT1 in the modulation of endothelial cell function, particularly concerning deep vein thrombosis (DVT) in the lower limbs. This discovery, articulated by Xiang, Zhang, Liu, and colleagues, presents a remarkable insight into [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320936</post-id>	</item>
		<item>
		<title>Caroline Y. Noh: Early Career Investigator Spotlight</title>
		<link>https://bioengineer.org/caroline-y-noh-early-career-investigator-spotlight/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 15:49:34 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Bioinformatics** **Açıklama:** 1. **Pediatric Research:** Makalenin ana odağı pediatrik araştırmalar ve çocuk sağlığıdır. 2. **Precision Medicine:** Noh'un çalışmalarında vurgulanan]]></category>
		<category><![CDATA[Early Career Investigator]]></category>
		<category><![CDATA[gelişimsel a]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **Pediatric Research]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/caroline-y-noh-early-career-investigator-spotlight/</guid>

					<description><![CDATA[In the rapidly evolving world of pediatric research, early career investigators are the torchbearers of innovation, bringing fresh perspectives and groundbreaking insights to complex medical challenges. Caroline Y. Noh exemplifies this new wave of scientific thinkers. Her latest work, as highlighted in the Pediatric Research journal, delves deep into crucial elements shaping pediatric health outcomes [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317782</post-id>	</item>
		<item>
		<title>Multi-Omics Reveal Cuproptosis Genes in Parkinson’s</title>
		<link>https://bioengineer.org/multi-omics-reveal-cuproptosis-genes-in-parkinsons/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jan 2026 18:43:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cuproptosis]]></category>
		<category><![CDATA[Makalenin içeriğine ve ana temalarına göre en uygun 5 etiket: **cuproptosis]]></category>
		<category><![CDATA[mitochondrial stress** * **cuproptosis:** Çalışmanın temel odağı olan bakır-bağımlı hücre ölüm mekanizması. * **Parkinson's disease:** Araştırmanın hedefled]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[multi-omics]]></category>
		<category><![CDATA[neurodegeneration]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<guid isPermaLink="false">https://bioengineer.org/multi-omics-reveal-cuproptosis-genes-in-parkinsons/</guid>

					<description><![CDATA[In an exciting breakthrough that could pave the way for novel therapeutic strategies in neurodegenerative disorders, researchers Zhang and Wang have unveiled intricate molecular mechanisms linking cuproptosis-related genes to the pathogenesis of Parkinson’s disease. This multi-omic study, recently published in the prestigious journal npj Parkinson’s Disease, unravels how copper-induced cell death pathways converge with genetic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317569</post-id>	</item>
		<item>
		<title>CD39 Polymorphism Drives Lung Clots in Sickle Cell</title>
		<link>https://bioengineer.org/cd39-polymorphism-drives-lung-clots-in-sickle-cell/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jan 2026 17:03:29 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **CD39 polymorphism]]></category>
		<category><![CDATA[lung thrombosis]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[sickle cell disease]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cd39-polymorphism-drives-lung-clots-in-sickle-cell/</guid>

					<description><![CDATA[In a groundbreaking study poised to redefine our understanding of sickle cell disease complications, researchers have uncovered a critical genetic variation that drives the formation of life-threatening lung thrombosis. The investigation, led by Brzoska, Kaminski, Katoch, and colleagues, centers on a polymorphism of the CD39 gene, revealing its pivotal role in promoting clot formation within [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316893</post-id>	</item>
		<item>
		<title>Obesity’s Complex Risks on Breast Cancer Outcomes</title>
		<link>https://bioengineer.org/obesitys-complex-risks-on-breast-cancer-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 19:25:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bariatric surgery outcomes** * **Obesity and breast cancer:** Ana konuyu doğrudan yansıtır. * **Molecular mechanisms:** Adipokinler]]></category>
		<category><![CDATA[Breast cancer prognosis]]></category>
		<category><![CDATA[FTO geni]]></category>
		<category><![CDATA[ilişkinin kendisi. * **Moleküler mekanizmalar:** Adipokinler]]></category>
		<category><![CDATA[inflamasyon gibi detaylı]]></category>
		<category><![CDATA[Klinik prognoz]]></category>
		<category><![CDATA[kronik inflamasyon]]></category>
		<category><![CDATA[Makale içeriğine göre en uygun 5 etiket: **Obesity and breast cancer]]></category>
		<category><![CDATA[Menopausal status impact]]></category>
		<category><![CDATA[Menopozal durum]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[Moleküler mekanizmalar]]></category>
		<category><![CDATA[Obezite müdahaleleri * **Obezite ve meme kanseri:** Ana konu]]></category>
		<category><![CDATA[Obezite ve meme kanseri]]></category>
		<category><![CDATA[östrojen metabolizması]]></category>
		<guid isPermaLink="false">https://bioengineer.org/obesitys-complex-risks-on-breast-cancer-outcomes/</guid>

					<description><![CDATA[The rising tide of breast cancer has emerged as a global health crisis, claiming its position as the most common malignant tumor and leading cause of cancer mortality among women worldwide. While advances in treatment have transformed many forms of cancer into manageable conditions, the intricate nature of breast cancer pathogenesis continues to challenge scientists [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316625</post-id>	</item>
		<item>
		<title>MSLN Activates EGFR-ERK1/2 to Drive Liver Metastasis</title>
		<link>https://bioengineer.org/msln-activates-egfr-erk1-2-to-drive-liver-metastasis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 10 Jan 2026 06:52:17 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[EGFR-ERK1/2 signaling]]></category>
		<category><![CDATA[Makalenin içeriğine ve odak noktalarına göre en uygun 5 etiket: **Liver metastasis]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[MSLN protein]]></category>
		<guid isPermaLink="false">https://bioengineer.org/msln-activates-egfr-erk1-2-to-drive-liver-metastasis/</guid>

					<description><![CDATA[In a groundbreaking study published recently in Cell Death Discovery, researchers have unveiled a critical molecular mechanism underpinning the liver metastasis of breast cancer. The investigation centers on the MSLN protein, revealing how its interaction with the EGFR-ERK1/2 signaling pathway dramatically influences metastatic progression to the liver. This revelation not only enhances our molecular understanding [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315576</post-id>	</item>
		<item>
		<title>IAPs in Cancer: Mechanisms, Prognosis, and Therapy</title>
		<link>https://bioengineer.org/iaps-in-cancer-mechanisms-prognosis-and-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jan 2026 05:06:49 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer therapy]]></category>
		<category><![CDATA[Inhibitor of Apoptosis Proteins]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[Prognostic biomarkers]]></category>
		<category><![CDATA[translational medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/iaps-in-cancer-mechanisms-prognosis-and-therapy/</guid>

					<description><![CDATA[In a groundbreaking exploration of cancer biology, the recent publication by Teng, Z., Teng, L., and Xie, J. delves into the intricate world of Inhibitor of Apoptosis Proteins (IAPs) and their multifaceted roles in cancer. The detailed study, entitled “IAPs in cancers: molecular mechanisms, clinical prognostic value, and translational therapeutic potential,” opens new avenues for [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314767</post-id>	</item>
		<item>
		<title>Proteomic Smoking Signatures Linked to Disease, Mortality Risk</title>
		<link>https://bioengineer.org/proteomic-smoking-signatures-linked-to-disease-mortality-risk/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 24 Dec 2025 14:32:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[mortality risk]]></category>
		<category><![CDATA[Proteomic signatures]]></category>
		<category><![CDATA[Smoking-related diseases]]></category>
		<guid isPermaLink="false">https://bioengineer.org/proteomic-smoking-signatures-linked-to-disease-mortality-risk/</guid>

					<description><![CDATA[In a groundbreaking study published in Nature Communications, scientists have unveiled intricate proteomic signatures linked to smoking, shedding new light on how tobacco use alters the human body at the molecular level and predisposes individuals to a range of diseases and mortality. This pioneering research, conducted by a team led by Xiao, Liu, Argentieri, and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">310932</post-id>	</item>
		<item>
		<title>Long non-coding RNAs and VEGF in Ovarian Cancer</title>
		<link>https://bioengineer.org/long-non-coding-rnas-and-vegf-in-ovarian-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 14 Dec 2025 21:39:00 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Angiogenesis** **Kısa açıklama:** 1. **lncRNA and VEGF:** Makalenin temel odak noktası]]></category>
		<category><![CDATA[bu iki molekül arasındaki ilişkiyi doğrudan vurgular. 2. **Ovarian Cancer:** Çalışman]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **lncRNA and VEGF]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[Ovarian cancer]]></category>
		<category><![CDATA[therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/long-non-coding-rnas-and-vegf-in-ovarian-cancer/</guid>

					<description><![CDATA[Recent advances in cancer research have illuminated the intricate role of long non-coding RNAs (lncRNAs) in the pathophysiology of various malignancies. Among these, ovarian cancer stands out due to its complex molecular landscape and the urgent need for novel therapeutic strategies. A groundbreaking study by Abuarqoub et al. delves deep into the mechanisms linking lncRNAs [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307818</post-id>	</item>
		<item>
		<title>Proteome Atlas Unveils Diabetic Retinopathy Risks</title>
		<link>https://bioengineer.org/proteome-atlas-unveils-diabetic-retinopathy-risks/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 31 Oct 2025 21:26:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[proteome atlas]]></category>
		<category><![CDATA[risk prediction]]></category>
		<guid isPermaLink="false">https://bioengineer.org/proteome-atlas-unveils-diabetic-retinopathy-risks/</guid>

					<description><![CDATA[In a groundbreaking study that promises to reshape our understanding of diabetic retinopathy, researchers have unveiled an unprecedented proteome atlas that maps the intricate molecular landscape of this debilitating retinal disease. Published recently in Nature Communications, this work represents a paradigm shift in both the mechanistic insights and predictive capabilities regarding diabetic retinopathy, a leading [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">289925</post-id>	</item>
		<item>
		<title>Pericardium Develops as Distinct Heart Structure</title>
		<link>https://bioengineer.org/pericardium-develops-as-distinct-heart-structure/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 29 Sep 2025 18:16:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cardiac embryogenesis]]></category>
		<category><![CDATA[congenital heart disease]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[pericardium development]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/pericardium-develops-as-distinct-heart-structure/</guid>

					<description><![CDATA[In a groundbreaking study that redefines our understanding of cardiac development, researchers have uncovered that the pericardium, the protective sac enveloping the heart, emerges as a distinct anatomical structure during heart formation. This revelation challenges long-held assumptions in developmental biology, positioning the pericardium not as a mere byproduct of surrounding tissue but as an independently [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">273307</post-id>	</item>
		<item>
		<title>Scientists Focus on Lifecycle of Lethal Parasite</title>
		<link>https://bioengineer.org/scientists-focus-on-lifecycle-of-lethal-parasite/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 06 Jun 2025 20:11:52 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Chagas disease]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[parasite lifecycle]]></category>
		<category><![CDATA[therapeutic targets]]></category>
		<category><![CDATA[Trypanosoma cruzi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scientists-focus-on-lifecycle-of-lethal-parasite/</guid>

					<description><![CDATA[Chagas disease has long been recognized as a silent and insidious health threat across the Americas, often escaping detection until it manifests in severe, life-threatening complications. This neglected tropical disease is caused by the protozoan parasite Trypanosoma cruzi, which is transmitted through the feces of infected triatomine bugs, colloquially known as kissing bugs. Named for [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">248688</post-id>	</item>
		<item>
		<title>Inflammatory Signature Unites Severe Malaria Syndromes</title>
		<link>https://bioengineer.org/inflammatory-signature-unites-severe-malaria-syndromes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 18 May 2025 11:19:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Global health]]></category>
		<category><![CDATA[Inflammatory signature]]></category>
		<category><![CDATA[malaria inflammation]]></category>
		<category><![CDATA[malaria pathogenesis]]></category>
		<category><![CDATA[malaria research]]></category>
		<category><![CDATA[malaria severity]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[Multi-omics analysis]]></category>
		<category><![CDATA[severe malaria]]></category>
		<category><![CDATA[therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/inflammatory-signature-unites-severe-malaria-syndromes/</guid>

					<description><![CDATA[In a groundbreaking study published in Nature Communications, an international team of scientists has unveiled a shared inflammatory signature that links various severe malaria syndromes, shedding new light on the complex pathophysiology of one of the world’s deadliest infectious diseases. By leveraging cutting-edge transcriptomic, proteomic, and metabolomic technologies, the researchers have provided unprecedented insight into [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">245672</post-id>	</item>
	</channel>
</rss>
